CareDx Inc (CDNA)
NASDAQ: CDNA
· Real-Time Price · USD
19.05
0.46 (2.47%)
At close: Jun 16, 2025, 3:59 PM
19.50
2.39%
After-hours: Jun 16, 2025, 07:42 PM EDT
2.47% (1D)
| Bid | 18 |
| Market Cap | 1.06B |
| Revenue (ttm) | 346.42M |
| Net Income (ttm) | 58.85M |
| EPS (ttm) | 1.12 |
| PE Ratio (ttm) | 17 |
| Forward PE | 109.35 |
| Analyst | Buy |
| Ask | 19.8 |
| Volume | 656,750 |
| Avg. Volume (20D) | 1,019,931 |
| Open | 19.18 |
| Previous Close | 18.59 |
| Day's Range | 18.59 - 19.23 |
| 52-Week Range | 13.18 - 34.84 |
| Beta | 2.18 |
About CDNA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CDNA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CDNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+10.67%
CareDx shares are trading higher after the company...
Unlock content with
Pro Subscription
4 months ago
+11.16%
CareDx shares are trading higher after Chevy Chase Trust CIO Amy Raskin disclosed on CNBC's Halftime Report that she has bought the stock.
1 month ago · businesswire.com
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ (“CareDx” or the “Company”)— a leading precision medicine company focused on the discovery, development, and co...
